SCHEMBL4430882

SCHEMBL4430882

CCCCOP(=O)(O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.67
CES1 P23141 1/20 0.67
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
BCHE P06276 1/20 0.58
ACHE P22303 1/20 0.58
MAPK1 P28482 3/20 0.54
ALDH1A1 P00352 2/20 0.54
CYP3A4 P08684 2/20 0.54
HSD17B10 Q99714 2/20 0.54
TSHR P16473 1/20 0.54
AKR1C3 P42330 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
THRB P10828 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MGLL Q99685 2/20 0.49
BCL9 O00512 1/20 0.48
CTNNB1 P35222 1/20 0.48
MAPT P10636 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18444211 0.91 CES2 (0.59) CES2CES1CA1CA2BCHE
SCHEMBL18444075 0.91 CES2 (0.59) CES2CES1CA1CA2BCHE
SCHEMBL2545948 0.87 CES2 (0.73) CES2CES1CA1CA2BCHE
SCHEMBL28338626 0.85 CES2 (0.71) CES2CES1CA1CA2BCHE
SCHEMBL3233444 0.85 CA1 (0.75) CES2CES1CA1CA2BCHE
SCHEMBL6388669 0.84 CES2 (0.69) CES2CES1CA1CA2BCHE
SCHEMBL4542384 0.83 CES2 (0.63) CES2CES1CA1CA2BCHE
SCHEMBL3229969 0.83 CA1 (0.58) CES2CES1CA1CA2BCHE
SCHEMBL9238036 0.82 LPAR3 (0.56) TSHRTP53
SCHEMBL223704 0.81 CES1 (1.00) CES2CES1CA1CA2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097428-A2 BUTYRYLCHOLINESTERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES Mgp Biotechnologies, Inc. (US) 2009-09-09 EP disclosed
WO-2008055249-A2 BUTYRYLCHOLINESTERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES MGP BIOTECHNOLOGIES, INC. (US) 2008-05-08 WO disclosed